GORDON CARL L purchased 29.9% of their position (625K shares) of BLOSSOMHILL THERAPEUTICS, INC. on the open market
Open‑market purchase worth $10.00M — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/12/2026ACC: 0000947871-26-000785
Director
Since Aug 2026
+625K
Net shares
Net buyer
$10.00M
Total acquired
1
Open market trades
1B · 0S
5
Total transactions
2.71M acquired · 2.09M disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+1.04M
Price / share
—
Trade value
—
% of position
New position
8/10/2026
0.00→1.04M
Common Stock
Indirect
Shares
+1.05M
Price / share
—
Trade value
—
% of position
100.9%
8/10/2026
1.04M→2.09M
Common Stock
Indirect
Shares
+625K
Price / share
$16.00
Trade value
$10M
% of position
29.9%
8/10/2026
2.09M→2.71M
Total
Net shares
+2.71M
Net value
$10M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/10/2026 | C · Conversion | +1.04M | — | — | New position | 0.00 | 1.04M |
| Common Stock Indirect | 8/10/2026 | C · Conversion | +1.05M | — | — | 100.9% | 1.04M | 2.09M |
| Common Stock Indirect | 8/10/2026 | P · Purchase | +625K | $16.00 | $10M | 29.9% | 2.09M | 2.71M |
| Total | +2.71M | $10M | ||||||
Derivative Transactions2
Series A Preferred Stock
Indirect
Converts to
Common Stock
1.04M shares
Shares
−1.04M
Strike price
Held after
0.00
Exercisable
—
8/10/2026
Series B Preferred Stock
Indirect
Converts to
Common Stock
1.05M shares
Shares
−1.05M
Strike price
Held after
0.00
Exercisable
—
8/10/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Indirect | Common Stock1.04M shares | 8/10/2026 | C · Conversion | −1.04M | — | 0.00 | |
| Series B Preferred Stock Indirect | Common Stock1.05M shares | 8/10/2026 | C · Conversion | −1.05M | — | 0.00 |